Search Within

Marc Ladanyi

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (3)
Groups
  1. Advanced Practice Providers (10)
  2. Department of Pathology and Laboratory Medicine (10)
  3. GSK Faculty (10)
  4. Human Oncology and Pathogenesis Program (10)
  5. Tow Center for Developmental Oncology (TCDO) (10)
  6. Nursing (9)

More Groups

People
  1. Maria Arcila (9)
  2. Michael Berger (8)
  3. Alexander Drilon (6)
  4. Ahmet Dogan (5)
  5. Aijazuddin Syed (5)
  6. Amanda Dhaneshwar (5)

More People

Years
  1. 2024 (4)
  2. 2023 (3)
  3. 2022 (2)
  4. 2019 (1)
Publications
  1. Neuro-Oncology (3)
  2. Journal of Clinical Oncology (2)
  3. Cancer Discovery (1)
  4. Cancer Research (1)
  5. Cold Spring Harbor Molecular Case Studies (1)
  6. Journal of Cutaneous Pathology (1)

More Publications

Publishers
  1. Oxford University Press (3)
  2. American Association for Cancer Research (2)
  3. American Society of Clinical Oncology (2)
  4. Cold Spring Harbor Laboratory Press (1)
  5. Elsevier Science, Inc. (1)
  6. John Wiley & Sons (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • OncoKB: Automated somatic variant classification for rapid clinical decision making
    Meeting Abstract

    Suehnholz, S.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Cavender, K.; Preiser, B.; Konecny, J.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B. M.; Ucpinar, B. A.; Alano, T.; Doe-Tetteh, S.; DiNapoli, S.; Riviere-Cazaux, C.; Burns, T. C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Tracking the FDA precision oncology drug approval landscape in OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Quantifying the growth of clinical actionability in precision oncology using OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Zhang, H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Non-invasive diagnosis of brainstem gliomas in pediatric, adolescent, and young adult patients through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B.; Alano, T.; Doe-Tetteh, S.; Bouvier, N.; Li, S.; Stockfisch, E.; Huereca, C.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • A novel case of cutaneous myxoid spindle cell neoplasm with FMR1-ALK gene fusion and CD34/S100 co-expression
    Journal Article

    Kasago, I.; Aypar, U.; Sukhadia, P.; Vanderbilt, C.; Ladanyi, M.; Hurd, T.; Pulitzer, M.
    Journal of Cutaneous Pathology (2023)

    Fulltext@MSK | Save
  • OncoKB, MSK's precision oncology knowledge base
    Meeting Abstract

    Suehnholz, S. P.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; Ladanyi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Noninvasive diagnosis of gliomas through CSF CFDNA sequencing in pediatric and adolescent and young adult (AYA) patients
    Meeting Abstract

    Hill, K.; Miller, A. M.; Li, B. K.; Bouvier, N.; Li, S.; Alano, T.; Doe-Tetteh, S.; Huereca, C.; DiNapoli, S.; Lee, A.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Exceptional responders with invasive mucinous adenocarcinomas: A phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
    Journal Article

    Drilon, A.; Schoenfeld, A. J.; Arbour, K. C.; Litvak, A.; Ni, A.; Montecalvo, J.; Yu, H. A.; Panora, E.; Ahn, L.; Kennedy, M.; more...
    Cold Spring Harbor Molecular Case Studies (2019)

    Fulltext@MSK | Save